Partial Nephrectomy Techniques for Renal Preservation: Historical and Modern Approaches

Similar documents
Vincenzo Ficarra 1,2,3. Associate Editor BJU International

2 Adrenal Disease. Open Surgery. Andrew C. Novick SURGICAL ANATOMY

GUIDELINES ON RENAL CELL CARCINOMA

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

RAPN. in T1b Renal Masses? A. Mottrie. G. Denaeyer, P. Schatteman, G. Novara

Oncourology COMPLICATIONS OF PARTIAL NEPHRECTOMY AT OPERATIVE TREATMENT OF RENAL CELL CARCINOMA

Sex: 女 Age: 51 Occupation: 無 Admission date:92/07/22

IVC THROMBECTOMY: OPEN

Partial Nephrectomy Planning: Everybody s s doing it, you can to

Guidelines on Renal Cell

Financial and Other Disclosures

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer

Index. Note: Page numbers of article titles are in boldface type.

Diagnosis & Management of Kidney Trauma. LAU - Urology Residency Program LOP Urology Residents Meeting

Solitary Contralateral Adrenal Metastases after Nephrectomy for Renal Cell Carcinoma

RPLND: Tips and Tricks

GUIDELINES ON RENAL CELL CANCER

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Section Activity Activity Description Details Reference(s)

Management of Locally Reccurent Renal Cell Carcinoma. Jose A. Karam, MD, FACS Assistant Professor Department of Urology

Complex case Presentations

Laparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care

Laparoscopic Radical Nephrectomy- the current gold standard

Patient Selection for Ablative Therapies. Adrian D Joyce Leeds UK

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic

Lymphadenectomy in RCC: Yes, No, Clinical Trial?

Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report

LAPAROSCOPIC NEPHRON-SPARING SURGERY IN THE PRESENCE OF RENAL ARTERY DISEASE

Manchester Cancer. Guidelines for the management of renal cancer

COLON AND RECTAL CANCER

Surgical Therapy of GEP-NET: An Overview

Controversies in management of squamous esophageal cancer

The new TNM staging for renal cell carcinoma: what and why the urologists want to know.

COLON AND RECTAL CANCER

Challenges in RCC surgery. Treatment Goals. Surgical challenges. Management options in VHL associated RCCs

When to Integrate Surgery for Metatstatic Urothelial Cancers

Initial Series of Robotic Radical Nephrectomy with Vena Caval Tumor Thrombectomy

Patient Selection for Surgery in RCC with Thrombus. E. Jason Abel, M.D.

Indications For Partial

St. Dominic s Annual Cancer Report Outcomes

Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD

EVALUATION OF THE OUTCOME OF THE MANAGEMENT OF PATIENTS WITH RENAL CELL CARCINOMA

Small Renal Mass Guidelines. Clif Vestal, MD USMD Arlington, Texas

Melanoma Quality Reporting

Who are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav

Accomplishes fundamental surgical tenets of R0 resection with systematic nodal staging for NSCLC Equivalent survival for Stage 1A disease

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys?

RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management

Surgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting Renal Cell Carcinoma

Arieh L. Shalhav Is There a Risk in Robotic Nephroureterectomy?

Complex Thoracoscopic Resections for Locally Advanced Lung Cancer

T3 NSCLC: Chest Wall, Diaphragm, Mediastinum

Original article: new surgical approaches to the Klatskin tumour

Surgical Management of Renal Cancer. David Nicol Consultant Urologist

Radiology Pathology Conference

Hand-Assisted Laparoscopic Radical Nephrectomy in the Treatment of a Renal Cell Carcinoma with a Level II Vena Cava Thrombus

RECURRENT ADRENAL DISEASE. Megan Applewhite Endorama 2/19/2015 SR , SC

Imaging abdominal vascular emergencies. V.Stoynova

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

NEPHRECTOMY AUDIT. OCTOBER 1998-SEPTEMBER 2005 Dr. Sanjeev Bandi MBBS., FRCSI., FRACS(Urology) Mater Misericordiae Hospital, Mackay, Qld 4740

ROBOTIC PARTIAL NEPHRECTOMY: 15 YRS LATER

Uro-Assiut 2015 Robotic Nephron Sparing Surgery

11/21/13 CEA: 1.7 WNL

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

AUA Guidelines Renal Mass and Localized Kidney Cancer

1. Epidemiology of Esophageal Cancer 2. Operative Strategies 3. Minimally Invasive Esophagectomy 4. Video

Three-Dimensional Reconstruction of Renovascular-Tumor Anatomy to Facilitate Zero-Ischemia Partial Nephrectomy

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Department of Urology, Columbia University School of Medicine, New York, NY

STAGING AND FOLLOW-UP STRATEGIES

Guidelines for Laparoscopic Resection of Curable Colon and Rectal Cancer

Debulking of Extensive Neuroendocrine Liver Metastases

In any operation. Indications. Anaesthesia. Position of the patient. Incision. Steps of the operation. Complications.

CASE REPORT. Introduction. Case series reports. J Thorac Dis 2012;4(S1): DOI: /j.issn s003

Original Article A novel approach to locate renal artery during retroperitoneal laparoendoscopic single-site radical nephrectomy

Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Kidney Case # 1 DISCHARGE SUMMARY. Date: 08/25/2010. Admitted: 08/19/2010 Discharged: 08/25/2010

Minimal Access Cancer Management

MULTILOCULAR CYSTIC RENAL CELL CARCINOMA

Excretory urography (EU) or IVP US CT & radionuclide imaging

Definition of Synoptic Reporting

University of Colorado Health Sciences Center, Denver Colorado ******************** ******************

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Liver Tumors. Prof. Dr. Ahmed El - Samongy

Wilms Tumor and Neuroblastoma

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Imaging in gastric cancer

Aliu Sanni MD SUNY Downstate Medical Center August 16, 2012

Kidney Cancer. NCCN Evidence Blocks. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version NCCN.org.

Should the primary be treated in patients with metastatic disease? Upper Tract Urothelial Cancer

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

Case Scenario 1. Discharge Summary

ADJUVANT CHEMOTHERAPY...

Renal Parenchymal Neoplasms

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

Breast Surgery: Yesterday, Today and Tomorrow

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%

Head & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i

Transcription:

Partial Nephrectomy Techniques for Renal Preservation: Historical and Modern Approaches Cary N Robertson MD FACS Associate Professor Division of Urology Associate Director Urologic Oncology Duke Cancer Institute Duke University Medical Center Durham, North Carolina

Disclosures EDAP TMS, Inc. Consultant

Renal Cell Carcinoma 50% of cases diagnosed incidentally pt1nxm0 stage associated with a 90% cumulative 5 year survival Minimally invasive techniques available for the majority of cases Lymph node status may be predictive of failure Targeted therapies may be evolving for high risk patients

Renal Cell Carcinoma Cancer control determined by T stage of primary tumor and lymph node status Uncommon to underestimate venous involvement Lymph node involvement predicts failure Lymph node size may be misleading

Partial vs Radical Nephrectomy Cancer control for small tumors may be similar regardless of surgical approach Tumor location compared in series of small (< 4 cm) cancers treated by radical nephrectomy or partial nephrectomy 145 pts (mean f/u 4 yrs) T1N0M0 stage: Central Peripheral 94% 82% (5.7% vs 4.5% recurrence rate) Hafez, Novick, Butler J Urol 1998 159:1156

Radical Nephrectomy Principle of excision of fascia surrounding renal parenchyma and/or associated involved tissues Tumors > 4 cm optimal May be associated with local and distant disease Curative, palliative or cytoreductive

Radical Nephrectomy Surgical Approach: Retroperitoneal Retroperitoneal Flank Dorsal Lumbotomy Transabdominal Anterior subcostal Bilateral anterior subcostal (Chevron) Thoracoabdominal Laparascopic (HAL or Laparoscopic)

Lymphadenectomy Lymph node status accurately assessed with regional node dissection Lymph drainage multidirectional Lymph node dissection is not therapeutic unless bulky nodes are painful and obstructive (bowel or ureter) Lymph node dissection above left renal hilum increases risk of chylous ascites

Bulky Renal Cell Carcinoma 5-20 cm dimensional range Local invasion may occur Inflammatory response may confuse Hepatic invasion difficult to exclude Colon invasion even with moderate tumors Duodenal invasion defines unresectability Splenic/pancreatic invasion manageable

Bulky RCC Staging Abdominal CT MRI Chest CT Bone Scan Brain CT/MRI Ultrasound Arteriogram

Radical Nephrectomy for Bulky RCC Surgical planning mandatory: Determine superior extent of tumor Plan for retroperitoneal node dissection Anticipate vascular exposure requirements Bowel prep anticipating bowel resection Recruit consultants for pancreatectomy,liver resection,duodenal resection,vena cavotomy

TransabdominalSurgical Approach Bilateral anterior subcostal (Chevron) Excellent abdominal exposure Ideal for vascular/bowel dissection May limit access to suprahepatic vena cava Ease of closure advantageous Less pain than thoracoabdominal incision

Thoracoabdominal Surgical Approach Right side approach: Superior extent of right tumor accessible Liver displacement into chest Retroperitoneal node dissection Left side approach: Superior extent of tumor/spleen/pancreas Limited exposure of liver/vena cava

Cytoreductive Surgery for RCC Metastatic RCC may be associated with small primary tumors Bulky primary tumors are problematic for immunotherapy/chemotherapy Preparative nephrectomy usually successful but may be associated with performance decline or tumor progression in 25-40% pts

RCC Metastectomy Feasible removal of mass/nodes/mets Solitary pulmonary nodule: combined thoracoscopic resection Liver resection: adjacent capsule only Splenectomy in continuity Distal pancreatectomy Bowel resection in continuity

Summary Surgery is the primary treatment for RCC Large renal mass resection is feasible in a majority of cases Significant palliative benefit may be derived Careful planning mandatory Locally advanced disease does not preclude surgery for the symptomatic patient

Partial Nephrectomy for Renal Cell Carcinoma Czerny first described partial nephrectomy in 1890 In 1950 Vermooten proposed renal mass excision with a margin of normal kidney Novick established criteria for patient selection in bilateral and unilateral renal masses

Partial Nephrectomy Solitary kidney with renal mass Bilateral renal cell carcinoma Unilateral renal mass with contralateral renal abnormality or dysfunction Unilateral renal mass with risk for future renal dysfunction (calculus disease, diabetes)

Partial Nephrectomy Cancer control is equivalent to radical nephrectomy results 4% unilateral recurrence rate 1% contralateral tumor development rate 485 pts Cleveland clinic population with 92% cancer specific survival Hafez, Fergany, Novick J Urol 1999 162:1930

Partial Nephrectomy Recurrence may be local or distant: 327 pts Cleveland Clinic underwent partial nephrectomy 13(4%) developed local recurrence 25(7.6%) developed metastatic disease 0% local recurrence for T1N0M0 tumors 4.4% metastatic disease for T1N0M0 stage Hafez, Novick, Campbell J Urol 1997 157:2067

Partial Nephrectomy Recurrence patterns by stage: Local Distant T1N0M0 0% 4.4% T2N0M0 2% 5.3% T3aN0M0 8.2% 11.5% T3bN0M0 10.6% 14.9% Hafez, Novick, Campbell J Urol 1997 157: 2067

Partial Nephrectomy Surgical Approach: Flank Transabdominal Laparoscopic

Partial Nephrectomy Flank Approach Supracostal 11 th rib optimal Facilitates dissection of peripheral tumors Anterior, Posterior and Central tumors accessible Hilar dissection feasible Renal artery perfusion feasible Allows for mobilization and surface cooling with minimal disruption of abdominal contents

Partial Nephrectomy Transabdominal Approach Deeper dissection Anterior dissection only Mobilization of renal attachments more difficult Bowel manipulation required NOT RECOMMENDED

Partial Neprectomy Laparoscopic Approach Transabdominal vs retroperitoneal Hand-assisted technique preferred Compression vs hilar clamping 3cm or less sized tumors Surface cooling problematic Renal artery perfusion challenging

Summary Moderate to small tumors (1-4 cm) may be well managed with partial nephrectomy Equivalent cancer control is seen with partial vs radical nephrectomy in tumors < 4 cm Choice of surgical approach for partial nephrectomy is determined by tumor location and size

Partial Nephrectomy Renal preservation techniques are variable and guided by location and size of tumors: Warm ischemia/compression < 30 min Surface renal hypothermia/temporary arterial occlusion < 60 min Renal arterial perfusion/surface renal hypothermia < 90 min

Partial Nephrectomy Renal ischemia may be cold or warm Off clamp dissection becoming more popular Micro-dissection required for off clamp partial nephrectomy for medial tumors Peripheral tumors ideall suited for off clamp technique.

Partial Nephrectomy Isolated perfusion via laparoscopic technique feasible but difficult Warm ischemia preferred with minimal clamp time Ischemia related to residual decline in renal function Re-clamping for hemostasis occasionally required

Partial Nephrectomy Combination approach of selective arterial dissection and temporary arterial occlusion permits decreased clamp time Off clamp dissection technique may supplant hilar clamping in selected cases Careful hilar dissection prevents arterial injury

Summary Traditional techniques employ cold ischemia and parenchymal compression Modern techniques combine microdissection with off clamp approach Renal parenchymal repair remains variable but depends on adequate compression and vasculature control prior to unclamping

Summary Advances in minimally invasive surgery have changed traditional approaches to renal preservation. This will continue to be the major trend for the future. Further understanding of renal protective strategies will be centered on arterial dissection and hilar management improvements.